Genetic testing of the FBN1 gene in Chinese patients with Marfan/Marfan-like syndrome

Clin Chim Acta. 2016 Aug 1:459:30-35. doi: 10.1016/j.cca.2016.05.021. Epub 2016 May 24.

Abstract

Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder typically involving the ocular, skeletal and cardiovascular systems, and aortic aneurysms/dissection mainly contributes to its mortality. Here, we performed genetic testing of the FBN1 gene in 39 Chinese probands with Marfan/Marfan-like syndrome and their related family members by Sanger sequencing. In total, 29 pathogenic/likely pathogenic FBN1 mutations, including 17 novel ones, were identified. In addition, most MFS patients with aortic disease (62%) had a truncating or splicing mutation. These results expand the FBN1 mutation spectrum and enrich our knowledge of genotype-phenotype correlations. Genetic testing for MFS and its related aortic diseases is increasingly important for early intervention and treatment.

Keywords: Aortic disease; FBN1 gene; Genetic testing; Marfan syndrome.

MeSH terms

  • China
  • Female
  • Fibrillin-1 / blood
  • Fibrillin-1 / genetics*
  • Genetic Testing*
  • Humans
  • Male
  • Marfan Syndrome / blood
  • Marfan Syndrome / diagnosis
  • Marfan Syndrome / genetics*
  • Middle Aged
  • Mutation*

Substances

  • FBN1 protein, human
  • Fibrillin-1